With respect to the few studies conducted on humans, one study demonstrated that the intravenous administration of ACE inhibitors in coronary artery disease patients did not impact the production of angiotensin-(1–7), a finding that raises questions whether ACE inhibitors have any direct effects on ACE2-directed angiotensin II metabolism (Campbell et al., 2004). The gene discussed is ACE; the disease is coronary artery disorder.